Kyverna Therapeutics, Inc. (KYTX) Operating income 2023–2025
Kyverna Therapeutics, Inc. (KYTX) annual operating income history from SEC filings — each fiscal year as reported.
-$169.8MFY2025 · since FY2023: -$62.4M → -$169.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$169.8M | -19.1% |
| FY2024 | -$142.6M | -128.5% |
| FY2023 | -$62.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More KYTX financial trends
KYTX RevenueKYTX Net incomeKYTX Net marginKYTX Gross profitKYTX Gross marginKYTX Operating marginKYTX Operating cash flowKYTX Free cash flowKYTX Capital expendituresKYTX Return on equityKYTX Stock buybacksKYTX Dividends paidKYTX Total assetsKYTX Total liabilitiesKYTX Shareholders’ equityKYTX overview →